First trimester maternal serum free human chorionic gonadotropin as a predictor of adverse pregnancy outcome

Fetal Diagnosis and Therapy

Volumn 17, Issue 6, 2002, Pages 352-356

  Yaron, Yuval ^c   Ochshorn, Yifat ^a   Heifetz, Sigal ^b   Lehavi, Ofer ^a   Sapir, Yaron ^d   Orr Urtreger, Avi ^d  

^a LIS MATERNITY HOSPITAL   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d NONE

Author keywords

Biochemical screening; First trimester; Free hCG; Pregnancy outcome

Indexed keywords

CHORIONIC GONADOTROPIN; PROTEIN A;

ADULT; ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; DEMOGRAPHY; DOWN SYNDROME; EVALUATION; FEMALE; FETUS ECHOGRAPHY; FETUS MALFORMATION; FIRST TRIMESTER PREGNANCY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MATERNAL SERUM; OLIGOHYDRAMNIOS; PREGNANCY COMPLICATION; PREMATURE LABOR; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; SCREENING; SPONTANEOUS ABORTION; STATISTICAL ANALYSIS;

ABORTION, SPONTANEOUS; ADULT; CHORIONIC GONADOTROPIN; FEMALE; HUMANS; MASS SCREENING; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; RISK FACTORS;

EID: 0036974323     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065384     Document Type: Article

References (15)

1. Lieppman RE, Williams MA, Cheng EY, Resta R, Zingheim R, Hickok DE, Luthy DA: An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome. Am J Obstet Gynecol 1983;168:1852-1856.
2. Said ME, Campbell DM, Azzam ME, MacGillivray I: Beta-human chorionic gonadotrophin levels before and after the development of pre-eclampsia. Br J Obstet Gynaecol 1984;91:772-775.
3. Sorensen TK, Williams MA, Zingheim RW, Clement SJ, Hickok DE: Elevated second-trimester human chorionic gonadotropin and subsequent pregnancy-induced hypertension. Am J Obstet Gynecol 1993;169:834-838.
4. Wenstrom KD, Owen J, Boots LR, DuBard MB: Elevated second-trimester human chorionic gonadotropin levels in association with poor pregnancy outcome. Am J Obstet Gynecol 1994;171:1038-1041.
5. Yaron Y, Cherry M, Kramer RL, O'Brien JE, Hallak M, Johnson MP, Evans MI: Second-trimester maternal serum marker screening: Maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome. Am J Obstet Gynecol 1999;181:968-974.
6. Walton DL, Norem CT, Schoen EJ, Ray GT, Colby CJ: Second-trimester serum chorionic gonadotropin concentrations and complications and outcome of pregnancy. N Engl J Med 1999;341:2033-2038.
7. Van Rijn M, van der Schouw YT, Hagenaars AM, Visser GH, Christiaens GC: Adverse obstetric outcome in low- and high-risk pregnancies: Predictive value of maternal serum screening. Obstet Gynecol 1999;94:929-934.
8. Lee LC, Sheu BC, Shau WY, Liu DM, Lai TJ, Lee YH, Huang SC: Mid-trimester beta-hCG levels incorporated in a multifactorial model for the prediction of severe pre-eclampsia. Prenat Diagn 2000;20:738-743.
9. Spencer K: Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome. Prenat Diagn 2000;20:652-656.
10. Raty R, Koskinen P, Alanen A, Irjala K, Matinlauri I, Ekblad U: Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free beta-hCG levels. Prenat Diagn 1999;19:122-127.
11. Mikic TS, Johnson P: Second-trimester maternal serum beta-human chorionic gonadotrophin and pregnancy outcome. Br J Obstet Gynaecol 1999;106:598-600.
12. Utoro T, Jadi H, Nishimura Y, Itoh H: An immunopathological study on the placenta in pre-eclampsia. Kobe J Med Sci 1989;35:217-228.
13. Palacio M, Jouniaux E, Kingdom J, Dell E, Sheldrake A, Rodeck CH: Perinatal outcome in pregnancies with a positive serum screening for Down's syndrome due to elevated levels of free beta-human chorionic gonadotropin. Ultrasound Obstet Gynecol 1999;13:58-62.
14. Ong CY, Liao AW, Spencer K, Munim S, Nicolaides KH: First trimester maternal serum free beta-human chorionic gonadotrophin and pregnancy-associated plasma protein A as predictors of pregnancy complications. Br J Obstet Gynaecol 2000;107:1265-1270.
15. Morssink LP, Kornman LH, Hallahan TW, Kloosterman MD, Beekhuis JR, de Wolf BT, Mantingh A: Maternal serum levels of free beta-hCG and PAPP-A in the first trimester of pregnancy are not associated with subsequent fetal growth retardation or preterm delivery. Prenat Diagn 1998;18:147-152.